This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Kotobuki Pharmaceutical Co Ltd. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Kazuhiro Kosakai: Innovator in Cholesterol Management
Introduction
Kazuhiro Kosakai is a notable inventor based in Nagano, Japan. He has made significant contributions to the field of medicine, particularly in the development of agents aimed at lowering serum cholesterol levels. His work is crucial in the fight against atherosclerosis, a condition that can lead to serious cardiovascular diseases.
Latest Patents
Kazuhiro Kosakai holds 1 patent for a serum cholesterol lowering agent or preventative or therapeutic agent for atherosclerosis. This innovative agent comprises a combination of a compound represented by a specific general formula and a cholesterol biosynthesis inhibitor and/or a fibrate type cholesterol lowering agent. The formula includes various groups and components that work together to effectively lower cholesterol levels in the serum.
Career Highlights
Throughout his career, Kazuhiro has been associated with Kotobuki Pharmaceutical Co. Ltd., where he has focused on research and development in pharmaceutical sciences. His dedication to improving health outcomes through innovative solutions has positioned him as a key figure in his field.
Collaborations
Kazuhiro has collaborated with esteemed colleagues such as Hiroshi Tomiyama and Masayuki Yokota. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Kazuhiro Kosakai's contributions to cholesterol management through his innovative patent highlight his commitment to advancing medical science. His work continues to impact the field positively, offering hope for better health outcomes in patients with atherosclerosis.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile